Amikacin Sulfate Injection 250 mg/mL USP 4 mL x 10/Pack (RX)

Amikacin Sulfate is an antibiotic medication used to treat a variety of bacterial infections. It is a member of the aminoglycoside class of antibiotics and works by killing the bacteria causing the infection. Amikacin sulfate is typically administered through injection and is reserved for serious or potentially life-threatening infections that have not responded to other antibiotic treatments.

Amikacin Sulfate Injection 250 mg/mL USP Bacterial Infection Treatment 4 mL is a sterile, injectable antibiotic medication used to treat serious bacterial infections. It contains the active ingredient amikacin sulfate, which belongs to a class of drugs known as aminoglycoside antibiotics. Amikacin works by stopping the growth of bacteria, and is effective against a wide range of Gram-negative and some Gram-positive bacteria. This medication is commonly used in hospital settings to treat infections such as pneumonia, septicemia, urinary tract infections, and skin and soft tissue infections. It is usually given intravenously (directly into a vein) or intramuscularly (injected into a muscle) under the supervision of a healthcare professional. The 4 mL size refers to the volume of the medication in the vial.

Powerful Antibacterial Protection: Amikacin Sulfate Injection 250 mg/mL by Sagent

For serious, hospital-acquired or resistant infections, trust Amikacin Sulfate Injection 250 mg/mL USP 4 mL x 10/Pack by Sagent (NDC: 25021-0173-04). This high-potency aminoglycoside antibiotic is relied upon by healthcare professionals for its rapid bactericidal action and dependable results—delivered in convenient 4 mL vials (10 per pack) for efficient hospital inventory and on-demand treatment.

Uses

• Serious Gram-Negative Infections: Effective against E. coli, Pseudomonas aeruginosa, Proteus, Klebsiella, Enterobacter, and Serratia species.
• Sepsis and Bacteremia: Used in life-threatening bloodstream infections.
• Respiratory Tract Infections: Hospital-acquired pneumonia or infections due to susceptible organisms.
• Intra-abdominal and Urinary Tract Infections: Reserved for situations where less toxic antimicrobials are ineffective or contraindicated.
• Bone, Joint, Skin, and Soft Tissue Infections: For resistant or mixed-organism infections as determined by sensitivity testing.

Benefits

• Broad-Spectrum Bactericidal Activity: Potent against multidrug-resistant gram-negative bacteria.
• Rapid Onset: Delivers fast action in critically ill and high-risk patients.
• Convenient Multi-Vial Formulation: 10 single-use vials per pack ensures availability for multiple patients or dosing regimens.
• Hospital-Grade Quality: Manufactured by Sagent—renowned for safety, sterility, and consistency.
• Clear Dosage and Labeling: Each vial contains 1,000 mg (250 mg/mL in 4 mL) for flexible and accurate administration.

Specifications

Directions

For use by healthcare professionals only. Dosage is individualized by severity, site of infection, and patient factors.

1. Administration:
   • May be given by IV infusion or IM injection.
   • Usual adult and adolescent dose: 15 mg/kg/day divided every 8-12 hours, or as directed by your physician.
   • For children and infants: Dosing is adjusted by weight and age.
2. Preparation:
   • Inspect vial; solution should be clear and colorless.
   • For IV infusion, dilute in compatible solution and infuse over 30–60 minutes.
   • For IM, administer in a large muscle mass.
3. Duration:
   • Therapy typically lasts 7–10 days, adjusted per infection and clinical response.

Always consult full prescribing information and follow institutional protocols for dosing, preparation, and patient monitoring.

Side Effects

Common Side Effects:

• Injection site pain or irritation
• Nausea or vomiting
• Fever or headache

Serious/Rare Side Effects:

• Nephrotoxicity (kidney damage)
• Ototoxicity (hearing loss, ringing in the ears, dizziness)
• Neuromuscular blockade (muscle weakness or difficulty breathing, especially in patients with myasthenia gravis)
• Allergic reactions (rash, itching, swelling)

Notify your provider immediately if you experience decreased urination, hearing loss, severe dizziness, or difficulty breathing.

Warnings

• Renal & Auditory Monitoring Required: Risk of irreversible kidney and hearing damage—monitor renal function and hearing before and during therapy.
• Avoid Concomitant Ototoxic or Nephrotoxic Drugs: Exercise caution when used with other antibiotics, diuretics, or drugs affecting renal function.
• Pregnancy & Lactation: Use only if clearly indicated. Safety during pregnancy and breastfeeding not established.
• Neuromuscular Disorders: May worsen symptoms in patients with myasthenia gravis or Parkinson’s disease.
• Elderly & Pediatric Use: Adjust doses and increase monitoring in high-risk groups.
• For IV or IM Use Only: Not for intrathecal or intraperitoneal administration.

Why Choose Amikacin Sulfate Injection by Sagent?

Amikacin Sulfate Injection 250 mg/mL USP 4 mL x 10/Pack by Sagent (NDC: 25021-0173-04) delivers powerful, reliable, and sterile treatment for life-threatening infections. Trusted by hospitals and clinicians for safety, spectrum, and speed, it’s your frontline defense against resistant gram-negative pathogens.

Order Amikacin Sulfate Injection 250 mg/mL 4 mL x 10/Pack by Sagent today for uncompromising quality and optimal outcomes in critical care.